Brief: Creso Pharma Says Is No Longer Subject Of ASIC Investigation

Melodiol Global Health

21/11/2022 23:59

Nov 22 (Reuters) - Creso Pharma  CPH.AX :
    * CRESO IS NO LONGER SUBJECT OF ASIC INVESTIGATION
    * ASIC CONFIRMED TWO DIRECTORS OF CO & CFO OF CO ARE NOT
PERSONS
OF INTEREST IN INVESTIGATION
    * BOARD DOES NOT EXPECT THAT ANY ENFORCEMENT ACTION WILL BE
TAKEN
AGAINST CRESO PHARMA
    * ASIC'S INVESTIGATION CONCERNING TRADING IN CRESO PHARMA'S
SECURITIES BY EXTERNAL PARTIES IS ONGOING

Source text for Eikon:  ID:nASXMstCq 
Further company coverage:  CPH.AX 
 ((Reuters.Briefs@thomsonreuters.com;))